Aminophylline

Chemical formula: C₁₆H₂₄N₁₀O₄  Molecular mass: 420.426 g/mol  PubChem compound: 9433

Therapeutic indications

Aminophylline is indicated for:

Pulmonary oedema, paroxysmal nocturnal dyspnoea, status asthmaticus, acute bronchospasm

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Aminophylline is indicated for diseases of the cardiovascular system (e.g. an adjunct in the treatment of pulmonary oedema or paroxysmal nocturnal dyspnoea caused by left ventricular heart failure), reversible airways obstruction including status asthmaticus and acute bronchospasm.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Aminophylline is contraindicated in the following cases:

Acute porphyria

Acute intermittent porphyria

Xanthine derivatives

at least one of
Xanthine derivatives
Xanthine derivatives

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: AMINOPHYLLINE INJECTION BP Injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈